Changes in Beneficial Ownership · 4
Prenetics Global Limited
PRENASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1787747026.xml
Filing details
- Report period
- 2026-08-24
- Issuer
- Prenetics Global Ltd
- Issuer CIK
- 0001876431
- Trading symbol
- PRE
Reporting owner 1
- Name
- Rosin Brian J
- Reporting owner CIK
- 0001695607
- Relationship
- Officer
- Officer title
- CFO of IM8 (US) LLC
- Address
- UNIT 703-706, K11 ATELIER, 728 KINGS ROAD, QUARRY BAY, HONG KONG, HONG KONG, K3
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Share, par value $0.0015 per share | 2026-08-24 | P · Form 4 | 18,000 | A | 21.19 | 18,000 | D |
| Class A Ordinary Share, par value $0.0015 per share | 2026-08-25 | P · Form 4 | 5,100 | A | 22.80 | 23,100 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Signature 1
- Signed
- s/ Stephen Hoi Chun Lo, as attorney-in-fact for Brian Joseph Rosin
- Date
- 2026-08-26
Company context
Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 40 countries worldwide.